Fentonium bromide

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 04:13, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Fentonium bromide
Clinical data
ATC code
Pharmacokinetic data
Bioavailability1
Identifiers
  • [8-Methyl-8-[2-oxo-2-(4-phenylphenyl)ethyl]-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate bromide
CAS Number
PubChem CID
DrugBank
UNII
ECHA InfoCard100.025.018 Edit this at Wikidata
Chemical and physical data
FormulaC31H34BrNO4
Molar mass564.520 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Fentonium bromide (INN) is a belladonna derivative. In the US its patent number is 3,356,682.[1] It is sold by Sanofi-Aventis and Zambon.[2]

References

  1. ^ "Fentonium". DrugBank. 17 August 2016. Retrieved 19 December 2016.
  2. ^ "Ulcesium (fentonium bromide) drug & pharmaceuticals. Ulcesium available forms, doses, prices". www.medicatione.com. Retrieved 19 December 2016.



Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Fentonium_bromide&oldid=963846571"